Please assess the completion status of the following clinical trial:

Trial Title: Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent for this trial prior to any trial specific assessment.~* Male and female subjects with SBS-IF and CIC, receiving parenteral support (PS), secondary to surgical resection of the small intestine with \<200 cm from duodenojejunal flexure.~* Subject must require PS at least 2 days per week and be considered stable.~* No restorative surgery intended to change PS requirements in the trial period.~* Age ≥18 years at screening.~Exclusion Criteria:~* Pregnancy or lactation.~* Body mass index equal or higher than 30 kg/m2 at the time of screening.~* Major abdominal surgery in the last 6 months prior to screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Apraglutide SC injections, once weekly (Type: EXPERIMENTAL): Peptide analogue of GLP-2

Based on this trial design, predict the completion outcome and termination type (if applicable).